My research focuses on investigating the biology of breast tumors at the molecular level to identify characteristics of tumors that are resistant to hormone-based therapeutics, such as tamoxifen and aromatase inhibitors. With this information, researchers can develop alternative therapies to treat hormone-resistant tumors.
I have been recognized by The Ohio State University Wexner Medical Center for being in the top 10 percent nationally for patient satisfaction for the past seven years. I received the Stellar Practitioner for Compassionate Care Recognition from patients and caregivers as an exceptional physician. I was also selected as one of five women at Ohio State who distinguished themselves as “Medical Center Marvels,” and I was featured in Health1 magazine.
In addition to treating patients, I serve as interim academic chief of the Breast Oncology Section and as director of the Medical Oncology Fellowship Program in Breast Cancer for the Ohio State College of Medicine.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016
Kilpauk Medical College
University of Wales College of Med
3/1/1993 - 2/28/1995
Northern General Hospital Sheffield University
2/1/1990 - 6/3/1990
Withybush General Hospital
6/6/1990 - 7/31/1991
Llandough Hospital University of Wales
10/1/1991 - 2/28/1993
Mount Carmel East Hospital
7/1/2000 - 6/30/2002
Additional languages I speak
Specialties and conditions I treat
- Medical Oncology
- Breast Cancer
Locations where I practice
More about my work
Ohio State University Wexner Medical Ctr
7/1/2002 - 6/30/2006
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
- 10 Ohio State Cancer Research Projects Underway With Pelotonia Funding
- Possible Therapy For Tamoxifen-Resistant Breast Cancer Identified
- Pelotonia To Fund Additional Cancer Research At Ohio State
- Study Provides Molecular Rationale For Combining Targeted Agents To Treat Breast Cancer
- Media Advisory: Leading Breast Cancer Experts Available For Comment
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Ramaswamy has reported no financial relationships with medical device, research and/or drug companies.